APJ receptor agonism for metabolic syndrome
APJ 受体激动剂治疗代谢综合征
基本信息
- 批准号:9239698
- 负责人:
- 金额:$ 47.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:APLN geneAdipocytesAdipose tissueAdverse effectsAffinityAgonistAgreementAmericanAnimalsAntihypertensive AgentsBindingBiogenesisBiological AssayBiological MarkersBlood - brain barrier anatomyBlood GlucoseBlood VesselsBody Weight decreasedCaloriesCardiovascular systemCellsCenters for Disease Control and Prevention (U.S.)ChronicCoupledCritiquesCyclic AMPCytochrome P450DataDevelopmentDietDiseaseDrug KineticsEndothelial CellsEndotheliumEnzymesExhibitsFatty AcidsFatty LiverFatty acid glycerol estersFoodGTP-Binding Protein alpha Subunits, GsGlucose IntoleranceGoalsHalf-LifeHeart DiseasesHepaticHigh Density LipoproteinsHigh Fat DietHormonesHypertensionHypertriglyceridemiaIn VitroInsulinInsulin ResistanceKnockout MiceLeadLibrariesLifeLigandsLipolysisLymphatic vesselMetabolicMetabolic syndromeMitochondriaModalityModelingModificationMonitorMusMuscleNon-Insulin-Dependent Diabetes MellitusObesityObesity associated diseaseOralPalatePenetrationPeptidesPharmaceutical ChemistryPharmaceutical PreparationsPharmacologyPlasmaPlayProductionPropertyProteinsReportingResistanceRiskRodentSkeletal MuscleSourceSteatohepatitisStrokeTestingTimeTransgenic MiceTransport ProcessValidationWorkabdominal fatabsorptionadipokinesanalogcancer typeclinical developmentclinically relevantcytotoxicdesigndiabetic patientdisorder preventionefficacy studyefficacy testingfasting glucosefatty acid oxidationfatty acid transporthemodynamicshigh throughput screeningimprovedin vitro Modelin vivoinsulin sensitizing drugsknockout animalnovelradioligandreceptorrelease of sequestered calcium ion into cytoplasmresponsescaffoldsmall moleculetooluptake
项目摘要
The overall goal of this project is to develop apelin (APJ) receptor agonists to treat diet-induced obesity
(DIO) and related metabolic syndrome. Metabolic syndrome can lead to several life threatening conditions
including hypertension, heart disease, type II diabetes, steatohepatitis, stroke, and certain types of cancer.
Available medications to treat obesity have serious side effects and limited efficacy. Thus, new medications
around novel targets are needed. The APJ receptor is a G-protein coupled receptor (GPCR) protein that is
activated by apelin peptides and a newly described hormone called TODDLER/ELABELA. It is an emerging
multi-modal target for metabolic syndrome that needs pharmacological validation. Apelin is an insulin
sensitizer that promotes fatty acid oxidation. Apelin knockout (ko) mice have higher insulin levels and glucose
intolerance along with increased abdominal fat and higher bodyweight. Apelin through its interaction with APJ
can inhibit maturation of pre-adipocytes and lipolysis in mature adipocytes. Activation of APJ by apelin in the
endothelium leads to the formation of large, non-leaky lymphatic and blood vessels that restrict the transport
of FA and their uptake in adipose. In agreement with these data, apelin ko mice have vessels that are more
amenable to FA transport. Another report has indicated that apelin transgenic mice are resistant to DIO by
virtue of increased vascular mass and mitochondrial biogenesis in skeletal muscles. Non-peptide probes of this
receptor suitable for in vivo work are not available. We have identified a structurally novel agonist scaffold for
further development through high-throughput screening. We propose to refine our early lead compounds to
produce in vivo probes of APJ using three iterative specific aims. Through aim 1, synthesis and refinement of
APJ probes will continue using medicinal chemistry approaches. Through aim 2, these compounds will be
characterized using functional and radioligand displacement assays for APJ. Potent compounds will be then
characterized using a battery of ADMET and pharmacokinetic assays. Through aim 3, in vivo testing of the best
compounds will be performed in a chronic model of DIO in rodents. Completion of the project will
pharmacologically validate APJ as a target for medications development to treat metabolic syndrome and
produce advanced lead compounds for eventual clinical development.
本项目的总体目标是开发apelin(APJ)受体激动剂来治疗饮食诱导的肥胖
(DIO)和相关的代谢综合征。代谢综合征可导致几种危及生命的疾病
包括高血压、心脏病、II型糖尿病、脂肪性肝炎、中风和某些类型的癌症。
现有的治疗肥胖症的药物有严重的副作用和有限的疗效。因此,新的药物
围绕新的目标。APJ受体是一种G蛋白偶联受体(GPCR)蛋白,
由爱帕琳肽和新描述的称为TODDLER/ELABELA的激素激活。是新兴
需要药理学验证的代谢综合征的多模式靶点。爱帕琳是一种胰岛素
促进脂肪酸氧化的敏化剂。爱帕琳基因敲除(ko)小鼠具有更高的胰岛素水平和葡萄糖
不耐受沿着腹部脂肪增加和体重增加。Apelin通过与APJ的相互作用
可以抑制前脂肪细胞的成熟和成熟脂肪细胞的脂肪分解。apelin激活APJ
内皮导致形成大的、无渗漏的淋巴管和血管,限制了运输
脂肪酸及其在脂肪中的摄取与这些数据一致,apelin ko小鼠的血管比其他小鼠的血管更长,
适合FA运输。另一份报告表明,爱帕琳转基因小鼠通过以下途径对DIO具有抗性:
由于骨骼肌中血管质量和线粒体生物发生增加。这种非肽探针
没有适合于体内工作的受体。我们已经确定了一种结构新颖的激动剂支架,
通过高通量筛选进一步发展。我们建议改进我们早期的铅化合物,
使用三个迭代特定目标生成APJ的体内探针。通过目标1,综合和完善
APJ探测将继续使用药物化学方法。通过目标2,这些化合物将
使用功能性和放射性配体置换试验对APJ地区进行了表征。有效的化合物将在
使用一组ADMET和药代动力学测定表征。通过aim 3,在体内测试的最佳
将在啮齿动物的DIO慢性模型中进行化合物的研究。建成后将
验证APJ地区作为治疗代谢综合征药物开发的目标,
为最终的临床开发生产先进的先导化合物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RANGAN MAITRA其他文献
RANGAN MAITRA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RANGAN MAITRA', 18)}}的其他基金
Conduct Confirmatory and Specialized In Vitro Testing and Screening of Interventional Agents in Standard Formats
以标准格式对介入药物进行验证性和专门的体外测试和筛选
- 批准号:
10925108 - 财政年份:2023
- 资助金额:
$ 47.15万 - 项目类别:
Conduct In Vitro Screening of Interventional Agents in High Throughput Screening (HTS) Formats: High Throughput Screening to Identify HIV Inhibitors
以高通量筛选 (HTS) 形式对介入药物进行体外筛选:通过高通量筛选识别 HIV 抑制剂
- 批准号:
10925107 - 财政年份:2023
- 资助金额:
$ 47.15万 - 项目类别:
Preclinical Services for HIV Therapeutics: QA/QC Plan and Task Order Initiation Meeting
HIV 治疗的临床前服务:QA/QC 计划和任务订单启动会议
- 批准号:
10397451 - 财政年份:2021
- 资助金额:
$ 47.15万 - 项目类别:
Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences
合成大麻素暴露和药理学后果的调查
- 批准号:
10521643 - 财政年份:2016
- 资助金额:
$ 47.15万 - 项目类别:
Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences
合成大麻素暴露和药理学后果的调查
- 批准号:
10704595 - 财政年份:2016
- 资助金额:
$ 47.15万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Recruitment of brown adipocytes in visceral white adipose tissue by fibroblast growth factor 8b
成纤维细胞生长因子 8b 将棕色脂肪细胞募集到内脏白色脂肪组织中
- 批准号:
321208980 - 财政年份:2016
- 资助金额:
$ 47.15万 - 项目类别:
Research Grants
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8827438 - 财政年份:2014
- 资助金额:
$ 47.15万 - 项目类别:
Induction of brown-like adipocytes in white adipose tissue by food-derived factors
食物源性因子在白色脂肪组织中诱导棕色样脂肪细胞
- 批准号:
26450168 - 财政年份:2014
- 资助金额:
$ 47.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
WAT-on-a-chip - Development of a micofluidic, microphysiologic in vitro adipose tissue model for high-throughput drug screening based on hiPSC-derived adipocytes.
WAT-on-a-chip - 开发微流体、微生理体外脂肪组织模型,用于基于 hiPSC 衍生脂肪细胞的高通量药物筛选。
- 批准号:
257256526 - 财政年份:2014
- 资助金额:
$ 47.15万 - 项目类别:
Research Fellowships
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8828181 - 财政年份:2013
- 资助金额:
$ 47.15万 - 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8520690 - 财政年份:2013
- 资助金额:
$ 47.15万 - 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8629741 - 财政年份:2013
- 资助金额:
$ 47.15万 - 项目类别:
Effect of exercise training on formation of brite adipocytes within white adipose tissue
运动训练对白色脂肪组织内脂肪细胞形成的影响
- 批准号:
23700778 - 财政年份:2011
- 资助金额:
$ 47.15万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Investigation for the mechanisms of the emergence of brown adipocytes in white adipose tissue
白色脂肪组织中棕色脂肪细胞出现机制的研究
- 批准号:
21780261 - 财政年份:2009
- 资助金额:
$ 47.15万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
LOUISIANA COBRE: P1: INDUCE THERMOGENIC BROWN ADIPOCYTES IN WHITE ADIPOSE TISSUE
路易斯安那 COBRE:P1:在白色脂肪组织中诱导产热棕色脂肪细胞
- 批准号:
7610781 - 财政年份:2007
- 资助金额:
$ 47.15万 - 项目类别: